Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays

Clinical Chemistry

Volumn 55, Issue 1, 2009, Pages 101-108

  Mingels, Alma ^a   Jacobs, Leo ^a   Michielsen, Etienne ^b   Swaanenburg, Joost ^b   Wodzig, Will ^a   Van Dieijen Visser, Marja ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MARATHON RUNNER; NORMAL HUMAN; PROTEIN BLOOD LEVEL; REFERENCE VALUE;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HEALTH; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RUNNING; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

ELAGATIS;

EID: 58149218174     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.106427     Document Type: Article

References (41)

1. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA 3rd, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007;115:2358-68.
2. Tunstall Pedoe DS. Marathon cardiac deaths: the London experience. Sports Med 2007;37:448-50.
3. Roberts WO, Maron BJ. Evidence for decreasing occurrence of sudden cardiac death associated with the marathon. J Am Coll Cardiol 2005;46:1373-4.
4. Redelmeier DA, Greenwald JA. Competing risks of mortality with marathons: retrospective analysis. BMJ 2007;335:1275-7.
5. Scharhag J, Herrmann M, Urhausen A, Haschke M, Herrmann W, Kindermann W. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Am Heart J 2005;150:1128-34.
6. La Gerche A, Connelly KA, Mooney DJ, MacIsaac AI, Prior DL. Biochemical and functional abnormalities of left and right ventricular function following ultra-endurance exercise. Heart 2007;94:860-6.
7. Kratz A, Lewandrowski KB, Siegel AJ, Chun KY, Flood JG, Van Cott EM, Lee-Lewandrowski E. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol 2002;118:856-63.
8. Fortescue EB, Shin AY, Greenes DS, Mannix RC, Agarwal S, Feldman BJ, et al. Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med 2007;49:137-143.e1.
9. Leers MP, Schepers R, Baumgarten R. Effects of a long-distance run on cardiac markers in healthy athletes. Clin Chem Lab Med 2006;44:999-1003.
10. Michielsen EC, Wodzig WK, Van Dieijen-Visser MP. Cardiac troponin T release after prolonged strenuous exercise. Sports Med 2008;38:425-35.
11. Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242-9.
12. Lam Q, Black M, Youdell O, Spilsbury H, Schneider HG. Performance evaluation and subsequent clinical experience with the Abbott Automated Architect STAT Troponin-I assay. Clin Chem 2006;52:298-300.
13. Hickman PE, Koerbin G, Southcott E, Tate J, Dimeski G, Carter A, et al. Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Ann Clin Biochem 2007;44:285-9.
14. Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH, Cannon CP, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-51.
15. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
16. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004;50:327-32.
17. Giannitsis E, Katus HA. Comparison of cardiac troponin T and troponin I assays - implications of analytical and biochemical differences on clinical performance. Clin Lab 2004;50:521-8.
18. Panteghini M. The new definition of myocardial infarction and the impact of troponin determination on clinical practice. Int J Cardiol 2006;106:298-306.
19. Apple FS, Murakami MM. Serum and plasma cardiac troponin I 99th percentile reference values for 3 2nd-generation assays. Clin Chem 2007;53:1558-60.
20. International Federation of Clinical Chemistry Committee on Standardization of Markers of Cardiac Damage. http://www.ifcc.org/index.php? optioncom_remository&Itemid120&func=fileinfo&id=87 (Accessed September 2008).
21. Kurz K, Giannitsis E, Zehelein J, Katus HA. Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia. Clin Chem 2008;54:1234-8.
22. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65.
23. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995;26:1068-79.
24. Salton CJ, Chuang ML, O'Donnell CJ, Kupka MJ, Larson MG, Kissinger KV, et al. Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol 2002;39:1055-60.
25. Tate JR, Ferguson W, Bais R, Kostner K, Marwick T, Carter A. The determination of the 99th centile level for troponin assays in an Australian reference population. Ann Clin Biochem 2008;45:275-88.
26. Wu AHB, Fukushima N, Puskas R, Todd J, Goix P. Development and preliminary clinical validation of a high sensitivity assay for cardiac troponin using a capillary flow (single molecule) fluorescence detector. Clin Chem 2006;52:2157-9.
27. Todd J, Freese B, Lu A, Held D, Morey J, Livingston R, Goix P. Ultrasensitive flow-based immunoassays by use of single-molecule counting. Clin Chem 2007;53:1990-5.
28. Melanson SE, Tanasijevic MJ, Jarolim P. Cardiac troponin assays: a view from the clinical chemistry laboratory. Circulation 2007;116:e501-4.
29. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008;155:208-14.
30. Shave R, George K, Gaze D. The influence of exercise upon cardiac biomarkers: a practical guide for clinicians and scientists. Curr Med Chem 2007;14:1427-36.
31. Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston Marathon. Circulation 2006;114:2325-33.
32. Shave R, George KP, Atkinson G, Hart E, Middleton N, Whyte G, et al. Exercise-induced cardiac troponin T release: a meta-analysis. Med Sci Sports Exerc 2007;39:2099-106.
33. Siegel AJ, Januzzi J, Sluss P, Lee-Lewandrowski E, Wood M, Shirey T, Lewandrowski KB. Cardiac biomarkers, electrolytes, and other analytes in collapsed marathon runners: implications for the evaluation of runners following competition. Am J Clin Pathol 2008;129:948-51.
34. Koller A. Exercise-induced increases in cardiac troponins and prothrombotic markers. Med Sci Sports Exerc 2003;35:444-8.
35. Neumayr G, Gaenzer H, Pfister R, Sturm W, Schwarzacher SP, Eibl G, et al. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am J Cardiol 2001;87:369-71.
36. Neumayr G, Pfister R, Mitterbauer G, Maurer A, Gaenzer H, Sturm W, Hoertnagl H. Effect of the "Race Across The Alps" in elite cyclists on plasma cardiac troponins I and T. Am J Cardiol 2002;89:484-6.
37. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991;67:1360-7.
38. Michielsen EC, Diris JH, Kleijnen VW, Wodzig WK, Van Dieijen-Visser MP. Investigation of release and degradation of cardiac troponin T in patients with acute myocardial infarction. Clin Biochem 2007;40:851-5.
39. Hessel MH, Atsma DE, van der Valk EJ, Bax WH, Schalij MJ, van der Laarse A. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch 2008;455:979-86.
40. Herrmann M, Scharhag J, Miclea M, Urhausen A, Herrmann W, Kindermann W. Post-race kinetics of cardiac troponin T and I and N-terminal probrain natriuretic peptide in marathon runners. Clin Chem 2003;49:831-4.
41. Whyte G, George K, Shave R, Dawson E, Stephenson C, Edwards B, et al. Impact of marathon running on cardiac structure and function in recreational runners. Clin Sci (Lond) 2005;108:73-80.